2 research outputs found

    CHANGES IN THE STRUCTURAL CHARACTERISTICS OF PLATELETS AND LEUKOCYTES IN PATIENTS WITH ARTERIAL HYPERTENSION UNDER THE INFLUENCE OF A HYDROGEN SULFIDE DONOR

    Get PDF
    The aim of the research. The influence of hydrogen sulphide donor on some structural characteristics of platelets and leukocytes in patients with arterial hypertension was studied. Materials and methods. The survey involved patients (men) with hypertension aged 30–60 years, who were divided into 2 age groups: 30–40 years and 40–60 years. Control groups (healthy men without signs of hypertension) were randomized by age. Electron microscopic and morphometric research methods were used in the investigation. Results. Electron microscopic and morphometric evaluation of the structure of these cells has shown that it undergoes significant changes depending on patient’s age. In the persons of the older age group, the cells contained a reduced number of dense Ξ΄-granules and increased – Ξ±-granules, which may indicate an impaired serotonin balance and increased susceptibility to thrombogenesis. The younger age group presented structural changes in platelets in a reversed order. Adding hydrogen sulphide donor at a dose of 400 mg per day (phytopreparation Full Spectrum Garlic – Swanson Health Products, USA) to the traditional therapy of arterial hypertension leads to positive changes in the ultrastructure of the studied cells aimed at restoring the balance of serotonin, reducing the tendency to thrombogenesis, increasing the energy capacity of the mitochondrial apparatus. Conclusion. The obtained results indicate that detected effects significantly depend on the patient’s age (younger people respond more intensively) and the duration of the use of hydrogen sulphide donor (longer use is accompanied by more pronounced positive changes)

    Π―Π’Π›Π―Π•Π’Π‘Π― Π›Π˜ ΠžΠ Π“ΠΠΠžΠ‘ΠŸΠ•Π¦Π˜Π€Π˜Π§ΠΠžΠ™ Π•ΠšΠ‘ΠŸΠ Π•Π‘Π‘Π˜Π― Π“Π•ΠΠžΠ’-ΠšΠΠΠ”Π˜Π”ΠΠ’ΠžΠ’ (DJ1, PINK1) Π’ ВКАНЯΠ₯ ΠžΠ Π“ΠΠΠ˜Π—ΠœΠ ПРИ Π­ΠšΠ‘ΠŸΠ•Π Π˜ΠœΠ•ΠΠ’ΠΠ›Π¬ΠΠžΠœ ΠŸΠΠ ΠšΠ˜ΠΠ‘ΠžΠΠ˜Π—ΠœΠ• И Π•Π“Πž ΠŸΠΠ’ΠžΠ“Π•ΠΠ•Π’Π˜Π§Π•Π‘ΠšΠžΠ™ Π’Π•Π ΠΠŸΠ˜Π˜?

    No full text
    It have been studied  the changes in the structural and functional state of mitochondria and expression of PINK1 and DJ1 genes in brain tissue - medulla oblongata and striatum and lung and heart tissue in experimental parkinsonism and its pathogenetic treatment with the help of a broad-spectrum antihypoxant Kapikor. It was shown that undrt experimental parkinsonism, in addition to damage to the ultrastructure of the mitochondrial apparatus in cells of body tissues, there are significant changes in mRNA expression of DJ1 and PINK1 genes, which are associated with the formation of mitochondrial dysfunction. They have a multidirectional character in the tissues of the brain - decrease, and in the tissues of the heart and lungs - increase. The degree of such changes in expression is organ-specific and more pronounced in the tissues of the visceral organs than in the tissues of the brain. Also, it was shown that the use of broad-spectrum antioxidant, which contains mildenium dehydrate and gamma-butyrobetaine dihydrate, there are significant changes in the expression of mRNA genes DJ1 and PINK1, which are also organ-specific - the expression of mRNA of all DJ1 genes increased in to a greater extent, the expression of PINK1 gene mRNA decreased sharply in brain tissues, and also increased sharply in lung and heart tissues. The data obtained indicate a complex and ambiguous relationship between the level of expression of the studied candidate genes involved in the formation of experimental parkinsonism, and the severity of mitochondrial dysfunction, which is one of the pathogenetic causes of parkinsonism.Π˜Π·ΡƒΡ‡Π΅Π½Ρ‹ измСнСния структурно-Ρ„ΡƒΠ½ΠΊΡ†ΠΈΠΎΠ½Π°Π»ΡŒΠ½ΠΎΠ³ΠΎ состояния ΠΌΠΈΡ‚ΠΎΡ…ΠΎΠ½Π΄Ρ€ΠΈΠΉ ΠΈ экспрСссии Π³Π΅Π½ΠΎΠ² PINK1 ΠΈ DJ1 Π² Ρ‚ΠΊΠ°Π½ΠΈ Π³ΠΎΠ»ΠΎΠ²Π½ΠΎΠ³ΠΎ ΠΌΠΎΠ·Π³Π° - ΠΏΡ€ΠΎΠ΄ΠΎΠ»Π³ΠΎΠ²Π°Ρ‚ΠΎΠΌ ΠΌΠΎΠ·Π³Π΅ ΠΈ стриатумС, Π° Ρ‚Π°ΠΊΠΆΠ΅ Π² Ρ‚ΠΊΠ°Π½ΠΈ Π»Π΅Π³ΠΊΠΈΡ… ΠΈ сСрдца ΠΏΡ€ΠΈ ΡΠΊΡΠΏΠ΅Ρ€ΠΈΠΌΠ΅Π½Ρ‚Π°Π»ΡŒΠ½ΠΎΠΌ паркинсонизмС ΠΈ Π΅Π³ΠΎ патогСнСтичСском Π»Π΅Ρ‡Π΅Π½ΠΈΠΈ с ΠΏΠΎΠΌΠΎΡ‰ΡŒΡŽ антигипоксанта ΡˆΠΈΡ€ΠΎΠΊΠΎΠ³ΠΎ спСктра дСйствия  ΠšΠ°ΠΏΠΈΠΊΠΎΡ€Π°. Π‘Ρ‹Π»ΠΎ ΠΏΠΎΠΊΠ°Π·Π°Π½ΠΎ, Ρ‡Ρ‚ΠΎ ΠΏΡ€ΠΈ ΡΠΊΡΠΏΠ΅Ρ€ΠΈΠΌΠ΅Π½Ρ‚Π°Π»ΡŒΠ½ΠΎΠΌ паркинсонизмС, ΠΏΠΎΠΌΠΈΠΌΠΎ поврСТдСния ΡƒΠ»ΡŒΡ‚Ρ€Π°ΡΡ‚Ρ€ΡƒΠΊΡ‚ΡƒΡ€Ρ‹ ΠΌΠΈΡ‚ΠΎΡ…ΠΎΠ½Π΄Ρ€ΠΈΠ°Π»ΡŒΠ½ΠΎΠ³ΠΎ Π°ΠΏΠΏΠ°Ρ€Π°Ρ‚Π° Π² ΠΊΠ»Π΅Ρ‚ΠΊΠ°Ρ… Ρ‚ΠΊΠ°Π½Π΅ΠΉ ΠΎΡ€Π³Π°Π½ΠΈΠ·ΠΌΠ°, происходят Π·Π½Π°Ρ‡ΠΈΡ‚Π΅Π»ΡŒΠ½Ρ‹Π΅ измСнСния Π² экспрСссии мРНК Π³Π΅Π½ΠΎΠ² DJ1 ΠΈ PINK1, ΠΊΠΎΡ‚ΠΎΡ€Ρ‹Π΅ связаны с Ρ„ΠΎΡ€ΠΌΠΈΡ€ΠΎΠ²Π°Π½ΠΈΠ΅ΠΌ ΠΌΠΈΡ‚ΠΎΡ…ΠΎΠ½Π΄Ρ€ΠΈΠ°Π»ΡŒΠ½ΠΎΠΉ дисфункции. Π’ тканях Π³ΠΎΠ»ΠΎΠ²Π½ΠΎΠ³ΠΎ ΠΌΠΎΠ·Π³Π° ΠΎΠ½Π° ΠΈΠΌΠ΅Π΅Ρ‚ ΠΎΠ΄Π½ΠΎΠ½Π°ΠΏΡ€Π°Π²Π»Π΅Π½Π½Ρ‹ΠΉ Ρ…Π°Ρ€Π°ΠΊΡ‚Π΅Ρ€ - сниТаСтся, Π° Π² тканях сСрдца ΠΈ Π»Π΅Π³ΠΊΠΈΡ… - увСличиваСтся. Π‘Ρ‚Π΅ΠΏΠ΅Π½ΡŒ Ρ‚Π°ΠΊΠΈΡ… ΠΈΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΠΉ экспрСссии органоспСцифична ΠΈ Π±ΠΎΠ»Π΅Π΅ Π²Ρ‹Ρ€Π°ΠΆΠ΅Π½Π° Π² тканях Π²ΠΈΡΡ†Π΅Ρ€Π°Π»ΡŒΠ½Ρ‹Ρ… ΠΎΡ€Π³Π°Π½ΠΎΠ², Ρ‡Π΅ΠΌ Π² тканях ΠΌΠΎΠ·Π³Π°. Π’Π°ΠΊΠΆΠ΅ Π±Ρ‹Π»ΠΎ ΠΏΠΎΠΊΠ°Π·Π°Π½ΠΎ, Ρ‡Ρ‚ΠΎ ΠΏΡ€ΠΈ использовании антиоксиданта ΡˆΠΈΡ€ΠΎΠΊΠΎΠ³ΠΎ спСктра дСйствия, ΠΊΠΎΡ‚ΠΎΡ€Ρ‹ΠΉ содСрТит мильдония Π΄ΠΈΠ³ΠΈΠ΄Ρ€Π°Ρ‚ ΠΈ Π΄ΠΈΠ³ΠΈΠ΄Ρ€Π°Ρ‚ Π³Π°ΠΌΠΌΠ°-Π±ΡƒΡ‚ΠΈΡ€ΠΎΠ±Π΅Ρ‚Π°ΠΈΠ½Π°, Π½Π°Π±Π»ΡŽΠ΄Π°ΡŽΡ‚ΡΡ Π·Π½Π°Ρ‡ΠΈΡ‚Π΅Π»ΡŒΠ½Ρ‹Π΅ измСнСния Π² экспрСссии Π³Π΅Π½ΠΎΠ² мРНК DJ1 ΠΈ PINK1, ΠΊΠΎΡ‚ΠΎΡ€Ρ‹Π΅ Ρ‚Π°ΠΊΠΆΠ΅ ΡΠ²Π»ΡΡŽΡ‚ΡΡ органоспСцифичными - экспрСссия мРНК Π³Π΅Π½Π° DJ1 ΡƒΠ²Π΅Π»ΠΈΡ‡ΠΈΠ»ΠΈΡΡŒ Π² большСй стСпСни, экспрСссия мРНК Π³Π΅Π½Π° PINK1 Ρ€Π΅Π·ΠΊΠΎ снизилась Π² тканях ΠΌΠΎΠ·Π³Π°, Π° Ρ‚Π°ΠΊΠΆΠ΅ Ρ€Π΅Π·ΠΊΠΎ ΡƒΠ²Π΅Π»ΠΈΡ‡ΠΈΠ»Π°ΡΡŒ Π² тканях Π»Π΅Π³ΠΊΠΈΡ… ΠΈ сСрдца. ΠŸΠΎΠ»ΡƒΡ‡Π΅Π½Π½Ρ‹Π΅ Π΄Π°Π½Π½Ρ‹Π΅ ΡƒΠΊΠ°Π·Ρ‹Π²Π°ΡŽΡ‚ Π½Π° ΡΠ»ΠΎΠΆΠ½ΡƒΡŽ ΠΈ Π½Π΅ΠΎΠ΄Π½ΠΎΠ·Π½Π°Ρ‡Π½ΡƒΡŽ взаимосвязь ΠΌΠ΅ΠΆΠ΄Ρƒ ΡƒΡ€ΠΎΠ²Π½Π΅ΠΌ экспрСссии ΠΈΠ·ΡƒΡ‡Π°Π΅ΠΌΡ‹Ρ… Π³Π΅Π½ΠΎΠ²-ΠΊΠ°Π½Π΄ΠΈΠ΄Π°Ρ‚ΠΎΠ², ΡƒΡ‡Π°ΡΡ‚Π²ΡƒΡŽΡ‰ΠΈΡ… Π² Ρ„ΠΎΡ€ΠΌΠΈΡ€ΠΎΠ²Π°Π½ΠΈΠΈ ΡΠΊΡΠΏΠ΅Ρ€ΠΈΠΌΠ΅Π½Ρ‚Π°Π»ΡŒΠ½ΠΎΠ³ΠΎ паркинсонизма, ΠΈ Ρ‚ΡΠΆΠ΅ΡΡ‚ΡŒΡŽ ΠΌΠΈΡ‚ΠΎΡ…ΠΎΠ½Π΄Ρ€ΠΈΠ°Π»ΡŒΠ½ΠΎΠΉ дисфункции, которая являСтся ΠΎΠ΄Π½ΠΎΠΉ ΠΈΠ· патогСнСтичСских ΠΏΡ€ΠΈΡ‡ΠΈΠ½ паркинсонизма
    corecore